Antibody–drug conjugates come of age in oncology
Charles Dumontet(Université Claude Bernard Lyon 1), Alain Beck(Pierre Fabre (Germany)), Janice M. Reichert, John M. Lambert, Peter D. Senter(North Carolina Central University)
Cited by 772
Related Papers
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
|Clinical Cancer Research|2004|1.2k
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
|Nature Biotechnology|2003|1.2k
Arming antibodies: prospects and challenges for immunoconjugates
|Nature Biotechnology|2005|1k
cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity
|Blood|2003|918
Antibody-Drug Conjugates in Cancer Therapy
|Annual Review of Medicine|2012|763